Khabarovsk's new TB ward offers hope for drug-resistant patients after years of delays

A long-awaited tuberculosis ward has opened in Khabarovsk after years of construction. The 1.5-billion-ruble ($16.5 million) facility will treat up to 140 patients, focusing on severe and drug-resistant cases. Surgeries have already started, with one patient reporting success after years of failed treatment.

The new ward addresses a critical need in the Russian Far East, where tuberculosis remains widespread. Official reports from 2023 recorded 187 cases of multidrug-resistant TB in the Khabarovsk region alone. The facility is equipped to handle these complex cases, including those unresponsive to standard medication.

The modern building includes an intensive care unit for post-operative and critically ill patients. It also features isolated high-dependency rooms and accessible wards for people with disabilities. Over 300 million rubles ($3.3 million) was spent on advanced medical equipment, alongside operating theatres, a laboratory, and a dedicated admissions department. A patient who underwent surgery in the new ward praised the comfortable conditions and modern facilities. Their treatment succeeded where years of medication had failed, highlighting the ward's potential impact.

The 140-bed facility will now serve as a specialised centre for severe TB cases in the region. Its opening comes as part of ongoing efforts to combat multidrug-resistant strains. The ward's advanced infrastructure aims to improve recovery rates and reduce long-term reliance on less effective treatments.